The intracellular domain of CD44 promotes the fusion of macrophages
Macrophages seed all tissues in which they have the ability, in specific and rare instances, to fuse with themselves and to differentiate into osteoclasts in bone or into giant cells in chronic inflammatory reactions. Although these cells play a central role in osteoporosis and in foreign body rejec...
Saved in:
Published in | Blood Vol. 107; no. 2; pp. 796 - 805 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
Elsevier Inc
15.01.2006
The Americain Society of Hematology American Society of Hematology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Macrophages seed all tissues in which they have the ability, in specific and rare instances, to fuse with themselves and to differentiate into osteoclasts in bone or into giant cells in chronic inflammatory reactions. Although these cells play a central role in osteoporosis and in foreign body rejection, respectively, the molecular mechanism used by macrophages to fuse remains poorly understood. Macrophages might also fuse with somatic and tumor cells to promote tissue repair and metastasis, respectively. We reported that CD44 expression is highly induced in macrophages at the onset of fusion in which it plays a role. We report now that the intracellular domain of CD44 (CD44ICD) is cleaved in macrophages undergoing fusion and that presenilin inhibitors prevent the release of CD44ICD and fusion. We also show that CD44ICD promotes the fusion of tissue macrophages and bone marrow-derived macrophages. Finally, we report that CD44ICD is localized in the nucleus of macrophages in which it promotes the activation of NF-κB. These observations open avenues to study the role of CD44ICD in blood cells and tumors. (Blood. 2006;107: 796-805) |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Supported by the National Institutes of Health (DE12110; A.V.). J.Z.K. was the recipient of a Boehringer Ingelheim Pharmaceutical Fellowship. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734. Prepublished online as Blood First Edition Paper, September 29, 2005; DOI 10.1182/blood-2005-05-1902. W.C. is lead author and generated 90% of the data presented in this manuscript. J.Z.K. subjected fusing alveolar macrophages to oligonucleotide microarray and identified presenilin as a transcript transiently expressed during macrophage fusion; she bred CD44-deficient and wild-type mice and isolated their bones for pQCT analysis. Her contribution to this work is essential. Q.Z. processed the bones from CD44-deficient and wild-type mice and subjected the sections to histomorphometry; although her data are mentioned as “data not shown,” her contribution to this work is essential. H.-Z.K. subjected the bones from CD44-deficient and wild-type mice to pQCT analysis; although the data he generated are mentioned as “data not shown” in “Discussion,” his contribution to this work is essential. C.C. is an expert in confocal microscopy and analyzed the subcellular localization of CD44ΔE-GFP. A.V. is the principal investigator of the laboratory, directed the team working on this project, and wrote the manuscript. |
ISSN: | 0006-4971 1528-0020 |
DOI: | 10.1182/blood-2005-05-1902 |